학술논문
Urinary bother, Urinalysis, and Two-Year Efficacy Follow-Up Results of Phase I Trial of Intravesical Bacillus Calmette-Guérin Combined with Intravenous Pembrolizumab in Recurrent or Persistent High-Grade Non-Muscle-Invasive Bladder Cancer after Previous Bacillus Calmette-Guérin Treatment
Document Type
Article
Author
Source
In: Clinical Genitourinary Cancer . (Clinical Genitourinary Cancer, June 2024, 22(3))
Subject
Language
English
ISSN
19380682
15587673
15587673